Spineway dropped 4% after the surgical implants and instruments company published net income of -3.1 million euros for 2022, compared with -1.6 million the previous year (excluding Spine Innovations), and operating income of -3.2 million.

The gross margin on sales nevertheless rose by 1.4 points to 69%, on annual sales of 7.4 million euros, an increase of 73% driven among other things by its long-standing customers, notably in Latin America.

'Backed by its new strengths and solidly established, Spineway confirms its ambition to become the innovative player in France and internationally, leader in less invasive spine treatments', says the company.

Copyright (c) 2023 CercleFinance.com. All rights reserved.